Bayer AG (BAYZF)
50.93
+1.55
(+3.14%)
USD |
OTCM |
Oct 26, 16:00
Bayer Market Cap : 50.03B for Oct. 26, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 26, 2026 | 50.03B |
| October 23, 2026 | 48.51B |
| October 22, 2026 | 48.51B |
| October 21, 2026 | 48.51B |
| October 20, 2026 | 48.51B |
| October 19, 2026 | 47.94B |
| October 16, 2026 | 48.83B |
| October 15, 2026 | 49.10B |
| October 14, 2026 | 48.16B |
| October 13, 2026 | 48.16B |
| October 12, 2026 | 47.99B |
| October 09, 2026 | 48.20B |
| October 08, 2026 | 47.16B |
| October 07, 2026 | 49.64B |
| October 06, 2026 | 49.64B |
| October 05, 2026 | 48.62B |
| October 02, 2026 | 51.86B |
| October 01, 2026 | 49.15B |
| September 30, 2026 | 54.21B |
| September 29, 2026 | 54.38B |
| September 28, 2026 | 56.59B |
| September 25, 2026 | 55.67B |
| September 24, 2026 | 55.28B |
| September 23, 2026 | 55.77B |
| September 22, 2026 | 55.62B |
| Date | Value |
|---|---|
| September 21, 2026 | 55.15B |
| September 18, 2026 | 54.03B |
| September 17, 2026 | 55.39B |
| September 16, 2026 | 55.39B |
| September 15, 2026 | 56.43B |
| September 14, 2026 | 56.43B |
| September 11, 2026 | 55.50B |
| September 10, 2026 | 55.50B |
| September 09, 2026 | 55.50B |
| September 08, 2026 | 55.50B |
| September 04, 2026 | 55.50B |
| September 03, 2026 | 55.58B |
| September 02, 2026 | 55.58B |
| September 01, 2026 | 55.58B |
| August 31, 2026 | 55.35B |
| August 28, 2026 | 55.35B |
| August 27, 2026 | 55.35B |
| August 26, 2026 | 56.34B |
| August 25, 2026 | 56.34B |
| August 24, 2026 | 55.19B |
| August 21, 2026 | 54.97B |
| August 20, 2026 | 55.44B |
| August 19, 2026 | 53.65B |
| August 18, 2026 | 53.65B |
| August 17, 2026 | 53.65B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck KGaA | 20.73B |
| Breakthrough Chemistry, Inc. | 0.8756M |
| Cardiac Biotech Solutions, Inc. | 5.164M |
| Fresenius SE & Co. KGaA | 29.13B |
| Carl Zeiss Meditec AG | 3.451B |
Market Cap Related Metrics
| PS Ratio | 0.9454 |
| Price to Book Value | 1.479 |
| Price to Free Cash Flow | 56.41 |
| Price | 50.93 |
| Earnings Yield | -4.02% |
| Operating PE Ratio | 6.844 |
| Normalized PE Ratio | 25.78 |